PDS Biotechnology (PDSB) Tops Q2 EPS by 1c

PDS Biotechnology (NASDAQ: PDSB) reported Q2 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Google execs convened 'all-hands' meeting last week to address AI unit reorganizations amid staff concerns - Reuters
• Kenon Holdings (KEN) halted, news pending
• Ottawa weighs proposal on auto tariffs as it presses U.S. for reprieve - Globe and Mail